139 related articles for article (PubMed ID: 23515089)
1. Neutralization of five subgenotypes of Enterovirus 71 by Taiwanese human plasma and Taiwanese plasma derived intravenous immunoglobulin.
Wu CY; Wang HC; Wang KT; Weng SC; Chang WH; Shih DY; Lo CF; Wang DY
Biologicals; 2013 May; 41(3):154-7. PubMed ID: 23515089
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
Wang KT; Lin SJ; Wang HC; Chen PC; Lin JJ; Chiang JR; Chang CL; Shih DY; Lo CF; Wang DY
Biologicals; 2016 Jul; 44(4):183-190. PubMed ID: 27068365
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors.
Cao RY; Han JF; Jiang T; Tian X; Yu M; Deng YQ; Qin ED; Qin CF
J Clin Virol; 2011 Aug; 51(4):246-9. PubMed ID: 21641277
[TBL] [Abstract][Full Text] [Related]
4. Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.
Liu P; Yuan Y; Cui B; Huo Y; Bian L; Chen L; Liu S; Wang C; Xu Y; Tedcastle A; Gao F; Mao Q; Martin J; Liang Z
Viruses; 2021 Apr; 13(5):. PubMed ID: 33919184
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of intravenous immunoglobulin therapy for severe hand-foot-mouth disease: a review].
Cao R; Han J; Qin E; Qin C
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):712-6. PubMed ID: 21845837
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The Netherlands.
van der Sanden SM; Koen G; van Eijk H; Koekkoek SM; de Jong MD; Wolthers KC
Emerg Infect Dis; 2016 Sep; 22(9):1562-9. PubMed ID: 27533024
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulin.
Planitzer CB; Farcet MR; Schiff RI; Ochs HD; Kreil TR
J Med Virol; 2011 Feb; 83(2):305-10. PubMed ID: 21181927
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of enterovirus 71 infections in Taiwan.
Chia MY; Chiang PS; Chung WY; Luo ST; Lee MS
Pediatr Neonatol; 2014 Aug; 55(4):243-9. PubMed ID: 24120535
[TBL] [Abstract][Full Text] [Related]
9. Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers.
Chou AH; Liu CC; Chang JY; Jiang R; Hsieh YC; Tsao A; Wu CL; Huang JL; Fung CP; Hsieh SM; Wang YF; Wang JR; Hu MH; Chiang JR; Su IJ; Chong PC
PLoS One; 2013; 8(11):e79783. PubMed ID: 24278177
[TBL] [Abstract][Full Text] [Related]
10. Presence of high-titer neutralizing antibodies against enterovirus 71 in intravenous immunoglobulin manufactured from Chinese donors.
Cao R; Han J; Deng Y; Yu M; Qin E; Qin C
Clin Infect Dis; 2010 Jan; 50(1):125-6. PubMed ID: 20001529
[No Abstract] [Full Text] [Related]
11. Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.
Huang ML; Chiang PS; Chia MY; Luo ST; Chang LY; Lin TY; Ho MS; Lee MS
PLoS Negl Trop Dis; 2013; 7(2):e2067. PubMed ID: 23459633
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies for diagnosis of enterovirus 71.
Xu L; Huang KJ; Ho TS; Liu CC; Lee YR; Lin CY; Shiuan D; Jiang XH
Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):386-94. PubMed ID: 24328741
[TBL] [Abstract][Full Text] [Related]
13. The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.
Mao Q; Cheng T; Zhu F; Li J; Wang Y; Li Y; Gao F; Yang L; Yao X; Shao J; Xia N; Liang Z; Wang J
PLoS One; 2013; 8(11):e79599. PubMed ID: 24260259
[TBL] [Abstract][Full Text] [Related]
14. An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features.
Lee MS; Lin TY; Chiang PS; Li WC; Luo ST; Tsao KC; Liou GY; Huang ML; Hsia SH; Huang YC; Chang SC
Pediatr Infect Dis J; 2010 Nov; 29(11):1030-4. PubMed ID: 20543760
[TBL] [Abstract][Full Text] [Related]
15. Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity.
Jia Q; Ng Q; Chin W; Meng T; Chow VTK; Wang CI; Kwang J; He F
Sci Rep; 2017 Apr; 7():46402. PubMed ID: 28422137
[TBL] [Abstract][Full Text] [Related]
16. Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity.
Chen Y; Li C; He D; Cheng T; Ge S; Shih JW; Zhao Q; Chen PJ; Zhang J; Xia N
Vaccine; 2013 Jan; 31(2):425-30. PubMed ID: 23088887
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city.
Huang WC; Huang LM; Kao CL; Lu CY; Shao PL; Cheng AL; Fan TY; Chi H; Chang LY
J Microbiol Immunol Infect; 2012 Apr; 45(2):96-101. PubMed ID: 22154997
[TBL] [Abstract][Full Text] [Related]
18. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL
Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888
[TBL] [Abstract][Full Text] [Related]
19. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
[TBL] [Abstract][Full Text] [Related]
20. A Potent Virus-Specific Antibody-Secreting Cell Response to Acute Enterovirus 71 Infection in Children.
Huang KY; Lin JJ; Chiu CH; Yang S; Tsao KC; Huang YC; Lin TY
J Infect Dis; 2015 Sep; 212(5):808-17. PubMed ID: 25712974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
